Historical Stock Price
ETFs Holding CLDX »    CLDX Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
08/04/2022 $31.29 $34.40 $31.01 $34.40 1.02M
08/05/2022 $34.17 $37.10 $33.43 $36.69 876.20K
08/08/2022 $36.80 $37.69 $35.98 $37.47 666.40K
08/09/2022 $36.73 $37.52 $34.45 $35.28 606.50K
08/10/2022 $36.18 $37.75 $35.65 $37.32 454.20K
Celldex Therapeutics is a biopharmaceutical company focused on developing therapeutic monoclonal and bispecific antibodies. Co.'s clinical development programs include: CDX-0159, which is a human monoclonal antibody that specifically binds the receptor tyrosine kinase KIT; CDX-1140, which is a human monoclonal antibody targeted to CD40, a key activator of immune response, which is being studied in a Phase1 study; and CDX-527, which is a bispecific antibody that uses Co.'s proprietary anti-PD-L1 and CD27 human antibodies to couple CD27 co-stimulation with blockade of the PD-L1/PD-1 pathway, for which Co. has initiated a Phase 1 study in advanced solid tumors.
CLDX historical stock prices picture
Celldex Therapeutics (CLDX) has the following price history information. Looking back at CLDX historical stock prices for the last five trading days, on August 04, 2022, CLDX opened at $31.29, traded as high as $34.40 and as low as $31.01, and closed at $34.40. Trading volume was a total of 1.02M shares. On August 05, 2022, CLDX opened at $34.17, traded as high as $37.10 and as low as $33.43, and closed at $36.69. Trading volume was a total of 876.20K shares. On August 08, 2022, CLDX opened at $36.80, traded as high as $37.69 and as low as $35.98, and closed at $37.47. Trading volume was a total of 666.40K shares. On August 09, 2022, CLDX opened at $36.73, traded as high as $37.52 and as low as $34.45, and closed at $35.28. Trading volume was a total of 606.50K shares. On August 10, 2022, CLDX opened at $36.18, traded as high as $37.75 and as low as $35.65, and closed at $37.32. Trading volume was a total of 454.20K shares.

CLDX Historical Stock Prices By Date:

CLDX historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Celldex Therapeutics shares, starting with a $10,000 purchase of CLDX, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 08/14/2012
End date: 08/10/2022
Start price/share: $70.95
End price/share: $37.32
Dividends collected/share: $0.00
Total return: -47.40%
Average Annual Total Return: -6.23%
Starting investment: $10,000.00
Ending investment: $5,257.66
Years: 9.99
Date Close
08/04/2022$34.40
08/05/2022$36.69
08/08/2022$37.47
08/09/2022$35.28
08/10/2022$37.32
CLDX is categorized under the Healthcare sector; below are some other companies in the same sector:

CLRB Historical Stock Prices
CLRBW Historical Stock Prices
CLSD Historical Stock Prices
CLSN Historical Stock Prices
CLVS Historical Stock Prices
CMD Historical Stock Prices
CMN Historical Stock Prices
CMRX Historical Stock Prices
CNAT Historical Stock Prices
CNC Historical Stock Prices

Also explore: CLDX shares outstanding history

Email EnvelopeFree CLDX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

CLDX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.